Electrophysiology News and Research

RSS

Scientists monitor frequencies of brain activity to unleash new insights into how it works

Like listeners adjusting a high-tech radio, scientists at Washington University School of Medicine in St. Louis have tuned in to precise frequencies of brain activity to unleash new insights into how the brain works.

9 Feb 2011

DE-MRI holds promise for predicting risks of strokes

Researchers at the University of Utah's Comprehensive Arrhythmia and Research Management Center have found that delayed-enhancement magnetic resonance imaging holds promise for predicting the risks of strokes, the third leading cause of death in the U.S.

9 Feb 2011

Research provides new clues to understand link between deficits of AGPO-3, depression

The link between deficits of omega-3 poly-unsaturated fatty acids and the onset of depressive disorders is not new in the medical field. However, what has not been known until now is the brain mechanism by which diet can condition mental health to a certain extent.

5 Feb 2011

Scientists discover key clue that can lead to sudden cardiac deaths

Australian researchers have come one step closer to understanding how the rhythm of the heartbeat is controlled and why many common drugs, including some antibiotics, antihistamines and anti-psychotics, can cause a potentially fatal abnormal heart rhythm.

29 Jan 2011

Boston Scientific reports first U.S. use of Blazer Open-Irrigated Catheter in BLOCk-CTI clinical trial

Boston Scientific Corporation today announced the first use of the Blazer® Open-Irrigated Catheter in the U.S. as part of the BLOCk-CTI clinical trial. BLOCk-CTI is a prospective, randomized trial evaluating the safety and effectiveness of the Blazer Open-Irrigated Catheter in patients with sustained or recurrent Type 1 atrial flutter.

28 Jan 2011

Johnson & Johnson fourth quarter sales decreases 5.5% to $15.6 billion

Johnson & Johnson today announced sales of $15.6 billion for the fourth quarter of 2010, a decrease of 5.5% as compared to the fourth quarter of 2009. Operational sales declined 5.1% and the negative impact of currency was 0.4%. Domestic sales declined 8.1%, while international sales declined 3.1%, reflecting an operational decline of 2.3% and a negative currency impact of 0.8%.

25 Jan 2011

SCAI publishes guiding principles for development of radiation safety programs in cardiac catheterization laboratories

Today the Society for Cardiovascular Angiography and Interventions published guiding principles and best practices for the development of radiation safety programs in cardiac catheterization laboratories.

20 Jan 2011

Boston Scientific announces merger agreement to acquire Atritech

Boston Scientific Corporation today announced the signing of a definitive merger agreement, under which the Company will acquire Atritech, a privately held company based in Plymouth, Minnesota.

19 Jan 2011

Heart disease patients' skin cells may help test long QT syndrome

Skin cells from a patient with an inherited heart disease were the seeds of a stem cell experiment that could help researchers test specific treatments for the disease, known as long QT syndrome. The research results appear in the January 16 issue of the journal Nature.

18 Jan 2011

Endosense, Siemens Healthcare enter joint catheter ablation development project

Endosense, a Swiss medical technology company, and Siemens Healthcare, one of the world's largest suppliers to the healthcare industry, have agreed to commence a joint development project intended to integrate the contact-force data provided by Endosense's TactiCath® force-sensing ablation catheter with Siemens' electrophysiology solutions.

14 Jan 2011

BIOTRONIK announces FDA IDE approval and first patient enrollment for TOCCASTAR clinical trial

BIOTRONIK SE Co. & KG highlights two key milestones toward receiving premarket approval (PMA) of the TactiCath, a novel technology for treating atrial fibrillation (AF): FDA IDE (investigational device exemption) approval and the first patient enrollment of the TOCCASTAR (TactiCath Contact Force Ablation Catheter Study for Atrial Fibrillation) clinical trial.

14 Jan 2011

FDA accepts Merck's JANUMET extended-release formulation NDA for type 2 diabetes

Merck today announced that the New Drug Application (NDA) for the Company's investigational extended-release formulation of JANUMET for type 2 diabetes has been accepted for standard review by the U.S. Food and Drug Administration (FDA). The Company is also moving forward as planned with regulatory filings in countries outside the United States.

12 Jan 2011

Stereotaxis announces first successful cardiac ablation procedure with Vdrive robotic navigation system

Stereotaxis, Inc. announces the first successful cardiac ablation procedure with the Vdrive™ robotic navigation system as the company received CE Mark for this latest innovation.

11 Jan 2011

Baylor Hamilton offers Arctic Front Cardiac CryoAblation Catheter system treatment for paroxysmal atrial fibrillation

Physicians at Baylor Jack and Jane Hamilton Heart and Vascular Hospital are the first in North Texas to offer the Arctic Front® Cardiac CryoAblation Catheter system, the first and only cryoballoon in the United States indicated to treat drug refractory recurrent symptomatic paroxysmal atrial fibrillation (PAF), a serious heart rhythm disorder that affects millions of Americans.

11 Jan 2011

nContact Surgical removes 'Surgical' from company name

nContact Surgical, Inc., a cardiac ablation device manufacturer, announced today that it is changing the name under which it operates from nContact Surgical, Inc. to nContact, Inc. As the pioneer of interdisciplinary epicardial and endocardial cardiac ablation, the change represents the Company's further evolution towards closed chest approaches to treating common cardiac arrhythmias.

10 Jan 2011

$FDA approves Medtronic's Arctic Front Cardiac CryoAblation Catheter system for drug refractory PAF$

FDA approves Medtronic's Arctic Front Cardiac CryoAblation Catheter system for drug refractory PAF

Medtronic, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved its Arctic Front® Cardiac CryoAblation Catheter system, the first and only Cryoballoon in the United States indicated for the treatment of drug refractory paroxysmal atrial fibrillation (PAF). The Cryoballoon treatment involves a minimally-invasive procedure that efficiently creates circumferential lesions around the pulmonary vein, which is the source of erratic electrical signals that cause the irregular heartbeat.

20 Dec 2010

LUMEDX implements CardioInventory software at Iowa Health Systems' affiliate hospitals

LUMEDX Corporation, a leading provider of vendor-neutral, integrated cardiovascular imaging and information systems (CVIS), announced the successful implementation of CardioInventory at nine Iowa Health Systems (IHS) affiliate hospitals. The final go-live at St. Luke's Medical Center in Cedar Rapids represents an important milestone in the ongoing installation of a centralized, enterprise-wide LUMEDX cardiovascular image- and data-management system for Iowa Health System.

9 Dec 2010

St. Jude Medical announces advanced technologies for streamlined workflow in EP lab

St. Jude Medical, Inc., a global medical device company, today announced several new products that provide physicians and hospitals with the opportunity for improved efficiency and information connectivity in the electrophysiology (EP) lab. The EnSite Connect™ Remote Support feature, EnSite Courier™ Module, EnSite Velocity v2.0™ Software and recently launched EnSite Derexi™ Module are advanced technologies that allow a streamlined workflow within the EP lab.

9 Dec 2010

Stereotaxis awarded VA Federal Supply Schedule Contract for Niobe Remote Magnetic Navigation System

Stereotaxis, Inc. announced that the United States Department of Veteran Affairs awarded Stereotaxis a Federal Supply Schedule Contract for its Niobe® Remote Magnetic Navigation System, related service agreement, and disposable products. This contract, effective December 15, 2010, is for five years, with a five year renewal option.

7 Dec 2010

Sentara Heart Hospital commences procedures in AtriCure DEEP AF feasibility trial

Sentara Heart Hospital is breaking new ground in cardiac care and treatment. Surgeons and Cardiologists at Sentara Heart Hospital are first to begin enrolling and performing trial cases in the AtriCure DEEP AF feasibility trial. The first procedure in the country was performed in a new, state-of-the-art hybrid operating room at Sentara Heart Hospital by Jonathan Philpott, M.D., Director of the Sentara Atrial Fibrillation Surgery Program, Ian Woollett, M.D., and John Onufer, M.D., Medical Director of Cardiac Electrophysiology.

3 Dec 2010

Electrophysiology News and Research

Scientists monitor frequencies of brain activity to unleash new insights into how it works

DE-MRI holds promise for predicting risks of strokes

Research provides new clues to understand link between deficits of AGPO-3, depression

Scientists discover key clue that can lead to sudden cardiac deaths

Boston Scientific reports first U.S. use of Blazer Open-Irrigated Catheter in BLOCk-CTI clinical trial

Johnson & Johnson fourth quarter sales decreases 5.5% to $15.6 billion

SCAI publishes guiding principles for development of radiation safety programs in cardiac catheterization laboratories

Boston Scientific announces merger agreement to acquire Atritech

Heart disease patients' skin cells may help test long QT syndrome

Endosense, Siemens Healthcare enter joint catheter ablation development project

BIOTRONIK announces FDA IDE approval and first patient enrollment for TOCCASTAR clinical trial

FDA accepts Merck's JANUMET extended-release formulation NDA for type 2 diabetes

Stereotaxis announces first successful cardiac ablation procedure with Vdrive robotic navigation system

Baylor Hamilton offers Arctic Front Cardiac CryoAblation Catheter system treatment for paroxysmal atrial fibrillation

nContact Surgical removes 'Surgical' from company name

FDA approves Medtronic's Arctic Front Cardiac CryoAblation Catheter system for drug refractory PAF

LUMEDX implements CardioInventory software at Iowa Health Systems' affiliate hospitals

St. Jude Medical announces advanced technologies for streamlined workflow in EP lab

Stereotaxis awarded VA Federal Supply Schedule Contract for Niobe Remote Magnetic Navigation System

Sentara Heart Hospital commences procedures in AtriCure DEEP AF feasibility trial

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest Life Science News